UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
Related reading
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
Europe races to placate pharma as Donald Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere
US urged UK to offer better drug pricing deal to pharma companies
Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
US readies new pharmaceutical tariffs
Levies of 100% on certain medicines would implement threats Trump made last year
EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs